7 July 2025
First UPC decision on a second medical use patent, issued by the Düsseldorf Local Division (13 May 2025, CPC_CFI_505/2024)
On May 13, 2025, the Unified Patent Court (UPC), through the Düsseldorf Local Division, issued its first ever decision concerning a second medical use claim.
The case opposed Regeneron Pharmaceuticals Inc., proprietor of European patent AP 3 536 712 B1, and its exclusive licensee Sanofi Biotechnology SAS, which markets the (...)